Quotes 5-day view Delayed Nasdaq Stockholm
05/19/2022
05/20/2022
05/23/2022
05/24/2022
05/25/2022
Date
284.9(c)
286(c)
279.1(c)
279.1(c)
269
Last
707 033
675 617
527 269
508 011
409 901
Volume
-1.11%
+0.39%
-2.41%
0.00%
-3.62%
Change
Estimated financial data (e) SEK USD
Sales 2022
29 546 M
3 020 M
3 020 M
Net income 2022
3 563 M
364 M
364 M
Net Debt 2022
2 216 M
226 M
226 M
P/E ratio 2022
21,4x
Yield 2022
1,63%
Sales 2023
31 413 M
3 210 M
3 210 M
Net income 2023
4 016 M
410 M
410 M
Net cash position 2023
573 M
58,5 M
58,5 M
P/E ratio 2023
18,9x
Yield 2023
1,85%
Capitalization
76 018 M
7 769 M
7 769 M
EV / Sales 2022
2,65x
EV / Sales 2023
2,40x
Nbr of Employees
10 892
Free-Float
79,8%
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows:
- medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.;
- hospital sterilization equipment (29.4%);
- contamination...
All news about GETINGE AB
News in other languages on GETINGE AB
Analyst Recommendations on GETINGE AB
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends GETINGE AB
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
9
Last Close Price
279,10 SEK
Average target price
415,67 SEK
Spread / Average Target
48,9%
Please enable JavaScript in your browser's settings to use dynamic charts.